Mega Lifesciences PCL (BKK:MEGA)

Thailand flag Thailand · Delayed Price · Currency is THB
31.50
+0.50 (1.61%)
Oct 3, 2025, 4:35 PM ICT
1.61%
Market Cap27.46B
Revenue (ttm)14.31B
Net Income (ttm)1.86B
Shares Out871.87M
EPS (ttm)2.14
PE Ratio14.74
Forward PE12.69
Dividend1.60 (5.16%)
Ex-Dividend DateAug 27, 2025
Volume334,948
Average Volume803,109
Open31.00
Previous Close31.00
Day's Range31.00 - 31.50
52-Week Range24.30 - 41.25
Beta0.28
RSI53.36
Earnings DateNov 13, 2025

About Mega Lifesciences PCL

Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa. The company operates in three segments: Brands, Distribution, and Original Equipment Manufacture (OEM). It provides various medicines for allergies; blood circulation and memory; bone and joint; liver and digestive; diabetics; eyes, heart, and skin care; pain, sl... [Read more]

Sector Healthcare
Founded 1982
Employees 900
Stock Exchange Stock Exchange of Thailand
Ticker Symbol MEGA
Full Company Profile

Financial Performance

In 2024, Mega Lifesciences PCL's revenue was 15.39 billion, a decrease of -2.10% compared to the previous year's 15.72 billion. Earnings were 2.01 billion, an increase of 0.99%.

Financial Statements

News

There is no news available yet.